by In2Pharma | Jun 7, 2019 | News
Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...
by In2Pharma | May 14, 2019 | News
The Netherlands On 30 April 2019, the concept text for the Healthcare Transparency Register law was presented for consultation. With this concept law, the obligation for suppliers of medicines and medical devices to report financial relationships with healthcare...
by In2Pharma | May 14, 2019 | News
The Netherlands In the Netherlands, the court has ruled on a case in which a medical search term led to a Google Ad for a food supplement. The court decided that this is unacceptable publicity for medicines. The Google Ad for the food supplement appeared after typing...
by In2Pharma | Feb 28, 2019 | News
European Union In light of the withdrawal of the United Kingdom from the European Union, the European Commission has published a letter on the rules for batch testing of medicinal products after the Brexit. The competent authorities may allow marketing authorisation...
by In2Pharma | Jan 28, 2019 | News
The Netherlands After revision of the code for public advertising and medical self-care tools (CPMH), the code for the promotion of health products (CAG) and the code for advertising of medicines (CPG), various adjustments were made: To make the codes more...